COMPARISON BETWEEN DIFFERENT CONCENTRATIONS OF OZONE GAS AS AN INTRA-ARTICULAR INJECTION FOR TREATMENT OF INTERNAL DERANGEMENT OF TEMPROMANDIBULAR JOINT
1 other identifier
interventional
20
1 country
1
Brief Summary
The intra-articular injection is considered the first line of minimally invasive treatment of joint disease as it has an analgesic, antimicrobial effect and an immune system stimulating action as it is one of the most powerful detoxication agents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 5, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedApril 13, 2026
April 1, 2026
9 months
April 5, 2026
April 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Helkimo's Index
Each patient was scored on a scale of 0-5 points. The total dysfunction index (Di) is calculated by summing the scores across all parameters, with the following classifications:
6 months
Secondary Outcomes (1)
Maximum Mouth Opening
6 months
Study Arms (2)
Study Group
EXPERIMENTALPatients will be treated with 2ml ozone oxygen mixture with concentration 5 micron/ml
Control Group
ACTIVE COMPARATORPatients will be treated with 2ml ozone oxygen mixture with concentration 10 micron/ml
Interventions
Patients will be treated with 2ml ozone oxygen mixture with concentration 5 micron/ml
Patients will be treated with 2ml ozone oxygen mixture with concentration 10 micron/ml
Eligibility Criteria
You may qualify if:
- Adult patients above 18 years old.
- Patients suffering from sounds during condylar movements (clicking or popping).
- Patients suffering from limited mouth opening and impaired joint movements.
- Patients who did not respond to conservative treatment as a first line of treatment.
You may not qualify if:
- Patients with history of condylar fracture.
- Patients with degenerative joint disease.
- Coagulopathy blood disorders.
- Presence of infection at the site of injection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry, Alexandria University
Alexandria, Alexandria Governorate, 21523, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
yehia A El-Mahallawy, Phd
Faculty of Dentistry, Alexandria University, Alexandria, Alexandria
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2026
First Posted
April 13, 2026
Study Start
February 1, 2025
Primary Completion
October 30, 2025
Study Completion
April 1, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04